# AbbVie (ABBV) total assets: $133.96B in 2025

URL: https://funkfolio.com/stock/ABBV/total-assets

> AbbVie (ABBV) total assets were $133.96B at the end of fiscal 2025, down 0.9% from fiscal 2024. Over five fiscal years it shrank 2.3% a year.

---

## AbbVie (ABBV) total assets

**Total assets · fiscal 2025:** $133.96B at Dec 31, 2025

AbbVie (ABBV) had total assets of $133.96B at the end of fiscal 2025 (December 31, 2025). That is 0.9% lower than the $135.16B of fiscal 2024. Figures as of 18 Nov 2026, 05:25 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Total assets, fiscal 2025:** $133.96B
- **Change on fiscal 2024:** −0.9%
- **Growth, 5 years:** −2.3% a year
- **Growth, 10 years:** +9.7% a year
- **Highest on record:** $150.57B fiscal 2020
- **Lowest on record:** $27.01B fiscal 2012
- **Fiscal years on record:** 14 2012–2025

Figures as of 18 Nov 2026, 05:25 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### AbbVie total assets, in more detail

Over the five fiscal years to 2025 total assets shrank at a compound 2.3% a year; over ten years the rate was 9.7% a year. Across the 14 fiscal years on record (2012–2025), the highest was $150.57B in fiscal 2020 and the lowest $27.01B in fiscal 2012.

### Total assets by fiscal year

### AbbVie total assets, year by year

AbbVie (ABBV) total assets by fiscal year

| Fiscal year | Total assets | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $133.96B | 0.9% down | Dec 31, 2025 |
| 2024 | $135.16B | 0.3% up | Dec 31, 2024 |
| 2023 | $134.71B | 2.9% down | Dec 31, 2023 |
| 2022 | $138.81B | 5.3% down | Dec 31, 2022 |
| 2021 | $146.53B | 2.7% down | Dec 31, 2021 |
| 2020 | $150.57B | 69.0% up | Dec 31, 2020 |
| 2019 | $89.12B | 50.1% up | Dec 31, 2019 |
| 2018 | $59.35B | 16.2% down | Dec 31, 2018 |
| 2017 | $70.79B | 7.1% up | Dec 31, 2017 |
| 2016 | $66.10B | 24.6% up | Dec 31, 2016 |
| 2015 | $53.05B | 92.8% up | Dec 31, 2015 |
| 2014 | $27.51B | 5.8% down | Dec 31, 2014 |
| 2013 | $29.20B | 8.1% up | Dec 31, 2013 |
| 2012 | $27.01B | — | Dec 31, 2012 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

### How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

### Total assets at health care companies of similar size

Total assets of AbbVie and comparable companies

| Company | Total assets | Fiscal year |
| --- | --- | --- |
| [Eli Lilly LLY](https://funkfolio.com/stock/LLY/total-assets) | $112.48B | 2025 |
| [Johnson & Johnson JNJ](https://funkfolio.com/stock/JNJ/total-assets) | $199.21B | 2025 |
| AbbVie ABBV | $133.96B | 2025 |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/total-assets) | $136.87B | 2025 |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/total-assets) | $309.58B | 2025 |
| [Novartis NVS](https://funkfolio.com/stock/NVS/total-assets) | $110.95B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### AbbVie, figure by figure

- [AbbVie market cap](https://funkfolio.com/stock/ABBV/market-cap)
- [AbbVie revenue](https://funkfolio.com/stock/ABBV/revenue)
- [AbbVie earnings](https://funkfolio.com/stock/ABBV/earnings)
- [AbbVie earnings per share (EPS)](https://funkfolio.com/stock/ABBV/eps)
- [AbbVie P/E ratio](https://funkfolio.com/stock/ABBV/pe-ratio)
- [AbbVie P/S ratio](https://funkfolio.com/stock/ABBV/ps-ratio)
- [AbbVie P/B ratio](https://funkfolio.com/stock/ABBV/pb-ratio)
- [AbbVie free cash flow](https://funkfolio.com/stock/ABBV/free-cash-flow)
- [AbbVie operating margin](https://funkfolio.com/stock/ABBV/operating-margin)
- [AbbVie dividend](https://funkfolio.com/stock/ABBV/dividend)
- [AbbVie shares outstanding](https://funkfolio.com/stock/ABBV/shares-outstanding)
- [AbbVie total debt](https://funkfolio.com/stock/ABBV/total-debt)
- [AbbVie cash on hand](https://funkfolio.com/stock/ABBV/cash)
- [AbbVie return on equity (ROE)](https://funkfolio.com/stock/ABBV/roe)
- [AbbVie return on invested capital (ROIC)](https://funkfolio.com/stock/ABBV/roic)

[AbbVie (ABBV) overview: price, valuation and scorecard](https://funkfolio.com/stock/ABBV) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### AbbVie total assets: questions and answers

**How large are AbbVie's total assets?**

AbbVie (ABBV) had total assets of $133.96B at the end of fiscal 2025 (December 31, 2025). That is 0.9% lower than the $135.16B of fiscal 2024.

**What is the growth rate of AbbVie's total assets?**

Over the five fiscal years to 2025 total assets shrank at a compound 2.3% a year; over ten years the rate was 9.7% a year.

**What are the highest and lowest total assets figures on record for AbbVie?**

Across the 14 fiscal years on record (2012–2025), the highest was $150.57B in fiscal 2020 and the lowest $27.01B in fiscal 2012.

**How is AbbVie's total assets calculated?**

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

### Learn: total assets

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “AbbVie (ABBV) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/ABBV/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.
